Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

More articles from Short Communication

  • You have access
    Metabolic Activation of the Antibacterial Agent Triclocarban by Cytochrome P450 1A1 Yielding Glutathione Adducts
    Nils Helge Schebb, Jaya B. Muvvala, Dexter Morin, Alan R. Buckpitt, Bruce D. Hammock and Robert H. Rice
    Drug Metabolism and Disposition July 2014, 42 (7) 1098-1102; DOI: https://doi.org/10.1124/dmd.114.058206
  • You have access
    Screening of Specific Inhibitors for Human Carboxylesterases or Arylacetamide Deacetylase
    Mai Shimizu, Tatsuki Fukami, Miki Nakajima and Tsuyoshi Yokoi
    Drug Metabolism and Disposition July 2014, 42 (7) 1103-1109; DOI: https://doi.org/10.1124/dmd.114.056994
  • You have access
    Validation of uPA/SCID Mouse with Humanized Liver as a Human Liver Model: Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases by LC-MS/MS
    Sumio Ohtsuki, Hirotaka Kawakami, Tae Inoue, Kenji Nakamura, Chise Tateno, Yuki Katsukura, Wataru Obuchi, Yasuo Uchida, Junichi Kamiie, Toru Horie and Tetsuya Terasaki
    Drug Metabolism and Disposition June 2014, 42 (6) 1039-1043; DOI: https://doi.org/10.1124/dmd.114.057646
  • You have access
    Role of ABCG2 in Transport of the Mammalian Lignan Enterolactone and its Secretion into Milk in Abcg2 Knockout Mice
    Verónica Miguel, Jon Andoni Otero, Rocío García-Villalba, Francisco Tomás-Barberán, Juan Carlos Espín, Gracia Merino and Ana I. Álvarez
    Drug Metabolism and Disposition May 2014, 42 (5) 943-946; DOI: https://doi.org/10.1124/dmd.113.055970
  • You have access
    Generation of Major Human Excretory and Circulating Drug Metabolites Using a Hepatocyte Relay Method
    T. Eric Ballard, Christine C. Orozco and R. Scott Obach
    Drug Metabolism and Disposition May 2014, 42 (5) 899-902; DOI: https://doi.org/10.1124/dmd.114.057026
  • You have access
    Bedaquiline Metabolism: Enzymes and Novel Metabolites
    Ke Liu, Feng Li, Jie Lu, Shinlan Liu, Kenneth Dorko, Wen Xie and Xiaochao Ma
    Drug Metabolism and Disposition May 2014, 42 (5) 863-866; DOI: https://doi.org/10.1124/dmd.113.056119
  • You have access
    Evaluation of 23 Lots of Commercially Available Cryopreserved Hepatocytes for Induction Assays of Human Cytochromes P450
    Kanako Yajima, Yasuhiro Uno, Norie Murayama, Shotaro Uehara, Makiko Shimizu, Chika Nakamura, Kazuhide Iwasaki, Masahiro Utoh and Hiroshi Yamazaki
    Drug Metabolism and Disposition May 2014, 42 (5) 867-871; DOI: https://doi.org/10.1124/dmd.113.056804
  • You have access
    1-Aminobenzotriazole Coincubated with (S)-Warfarin Results in Potent Inactivation of CYP2C9
    Jasleen K. Sodhi, Kevin A. Ford, Sophie Mukadam, Susan Wong, Cornelis E. C. A. Hop, S. Cyrus Khojasteh and Jason S. Halladay
    Drug Metabolism and Disposition May 2014, 42 (5) 813-817; DOI: https://doi.org/10.1124/dmd.113.055913
  • You have access
    4β-Hydroxycholesterol as an Endogenous Biomarker of CYP3A Activity in Cynomolgus Monkeys
    Ke Li, Sylvia Zhao, Lingling Zhang, Xiaoyun Wu, Pan Shu, Yang Wang, Hao Feng, Zheming Gu and Helen Han Hsu
    Drug Metabolism and Disposition May 2014, 42 (5) 839-843; DOI: https://doi.org/10.1124/dmd.114.057224
  • You have access
    The Effect of ABCG2 and ABCC4 on the Pharmacokinetics of Methotrexate in the Brain
    Ramola Sane, Shu-Pei Wu, Rong Zhang and James M. Gallo
    Drug Metabolism and Disposition April 2014, 42 (4) 537-540; DOI: https://doi.org/10.1124/dmd.113.055228

Pages

  • Previous
  • Next
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 53
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics